Literature DB >> 228070

Polypeptides of the Epstein-Barr virus membrane antigen complex.

D A Thorley-Lawson, C M Edson.   

Abstract

Epstein-Barr virus (EBV)-associated membrane antigens have been purified from the plasma membranes of the producer cell line P3HR-1 NONO. The antigens were assayed with a specific rabbit anti-ebv antiserum using an 125I-labeled staphylococcal protein A binding assay. The antigens have been shown to be present on purified plasma membranes. Treatment of the plasma membranes with Triton X-100 allows the separation of two antigenically distinct classes of antigens, one soluble and one insoluble in the detergent. Immunoprecipitates of [125I5- and [35S]methionine-labeled, detergent-soluble antigens contained three major polypeptides of molecular weights of 350,000, 140,000, and 75,003 (on 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and several minor components. These polypeptides were all specifically precipitated from four EBV-producer cell lines, P3HR-1, P3HR-1 NONO, B95-8, and 7744. They could not be precipitated from producer cell lines treated with phosphonoacetic acid, which inhibits late viral functions, nor could they be precipitated from nonproducer cell lines. The 350,000 and 75,000 molecular weight polypeptides bound to Ricin and lentil lectin columns; however, most of the 140,000 molecular weight material did not. A component of molecular weight 220,000 (prominent only in P3HR-1 NONO) was probably a degradation product of the 350,000 molecular weight polypeptide.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228070      PMCID: PMC353577     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

4.  Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen.

Authors:  D Baron; J L Strominger
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

5.  Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines.

Authors:  J Luka; T Lindahl; G Klein
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

6.  Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.

Authors:  D A Thorley-Lawson
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  Papain solubilization of the Epstein-Barr virus-induced membrane antigen.

Authors:  G R Pearson; L F Qualtiere
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

9.  Studies on Epstein-Barr virus-related antigens. III. Purification of the virus-determined nuclear antigen (EBNA) from non-producer Raji cells.

Authors:  T Matsuo; N Hibi; S Nishi; H Hirai; T Osato
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

10.  Evidence that thyroglobulin contains nonidentical half molecule subunits.

Authors:  B van der Walt; B Kotzé; P P van Jaarsveld; H Edelhoch
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

View more
  25 in total

Review 1.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein.

Authors:  C M Edson; B A Hosler; R A Respess; D J Waters; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.

Authors:  Jin Qiu; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-10       Impact factor: 11.205

4.  Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.

Authors:  J Tanner; Y Whang; J Sample; A Sears; E Kieff
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Identification of the Epstein-Barr virus gp85 gene.

Authors:  T Heineman; M Gong; J Sample; E Kieff
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen.

Authors:  B C Strnad; T Schuster; R Klein; R F Hopkins; T Witmer; R H Neubauer; H Rabin
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

7.  An 88,000-Mr Giardia lamblia surface protein which is immunogenic in humans.

Authors:  C M Edson; M J Farthing; D A Thorley-Lawson; G T Keusch
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

8.  Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.

Authors:  J R North; A J Morgan; J L Thompson; M A Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

Authors:  S F Slovin; D M Frisman; C D Tsoukas; I Royston; S M Baird; S B Wormsley; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

10.  Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains.

Authors:  B Georg-Fries; N Mueller-Lantzsch
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.